Utilization of a cell‐penetrating peptide‐adaptor for delivery of human papillomavirus protein E2 into cervical cancer cells to arrest cell growth and promote cell death

Human papillomavirus (HPV) is the causative agent of nearly all forms of cervical cancer, which can arise upon viral integration into the host genome and concurrent loss of viral regulatory gene E2. Gene‐based delivery approaches show that E2 reintroduction reduces proliferative capacity and promotes apoptosis in vitro.

[1]  J. McMurry,et al.  A reversible cell penetrating peptide-cargo linkage allows dissection of cell penetrating peptide- and cargo-dependent effects on internalization and identifies new functionalities of putative endolytic peptides , 2022, Frontiers in Pharmacology.

[2]  Jonathan L. McMurry,et al.  A real-time assay for cell-penetrating peptide-mediated delivery of molecular cargos , 2021, bioRxiv.

[3]  A. Składanowski,et al.  Effective Drug Concentration and Selectivity Depends on Fraction of Primitive Cells , 2021, International journal of molecular sciences.

[4]  Jonathan L. McMurry,et al.  Breaking in and busting out: cell-penetrating peptides and the endosomal escape problem , 2017, Biomolecular concepts.

[5]  Akila N. Viswanathan,et al.  Cervical cancer in low and middle income countries: Addressing barriers to radiotherapy delivery , 2017, Gynecologic oncology reports.

[6]  Jonathan L. McMurry,et al.  A versatile cell-penetrating peptide-adaptor system for efficient delivery of molecular cargos to subcellular destinations , 2017, PloS one.

[7]  E. Garrido,et al.  Characterization of cervical cancer stem cell-like cells: phenotyping, stemness, and human papilloma virus co-receptor expression , 2016, Oncotarget.

[8]  P. Fisher,et al.  Gene Therapies for Cancer: Strategies, Challenges and Successes , 2015, Journal of cellular physiology.

[9]  Zhiqiang Liu,et al.  Western Blot: Technique, Theory and Trouble Shooting , 2014, North American journal of medical sciences.

[10]  Wim Quint,et al.  The biology and life-cycle of human papillomaviruses. , 2012, Vaccine.

[11]  Ping-Chang Yang,et al.  Western Blot: Technique, Theory, and Trouble Shooting , 2012, North American journal of medical sciences.

[12]  Y. Jacob,et al.  Large Scale Genotype Comparison of Human Papillomavirus E2-Host Interaction Networks Provides New Insights for E2 Molecular Functions , 2012, PLoS pathogens.

[13]  Jonathan L. McMurry,et al.  Rate, affinity and calcium dependence of nitric oxide synthase isoform binding to the primary physiological regulator calmodulin , 2011, The FEBS journal.

[14]  J. Beckmann,et al.  Cell-permeable peptides induce dose- and length-dependent cytotoxic effects. , 2007, Biochimica et biophysica acta.

[15]  Shwu‐Yuan Wu,et al.  Dynamic Localization of the Human Papillomavirus Type 11 Origin Binding Protein E2 through Mitosis While in Association with the Spindle Apparatus , 2006, Journal of Virology.

[16]  L. Banks,et al.  Regulation of Human Papillomavirus Type 16 E7 Activity through Direct Protein Interaction with the E2 Transcriptional Activator , 2006, Journal of Virology.

[17]  P. Stern,et al.  Diffusible VP22-E2 protein kills bystander cells and offers a route for cervical cancer gene therapy. , 2005, Human gene therapy.

[18]  F. Méchali,et al.  High-Risk But Not Low-Risk HPV E2 Proteins Bind to the APC Activators Cdh1 and Cdc20 and Cause Genomic Instability , 2005, Cell cycle.

[19]  L. Banks,et al.  Crosstalk between the human papillomavirus E2 transcriptional activator and the E6 oncoprotein , 2005, Oncogene.

[20]  P. Stern,et al.  Herpes simplex virus VP22–human papillomavirus E2 fusion proteins produced in mammalian or bacterial cells enter mammalian cells and induce apoptotic cell death , 2004, Biotechnology and applied biochemistry.

[21]  Shwu‐Yuan Wu,et al.  Human papillomavirus (HPV) origin-binding protein associates with mitotic spindles to enable viral DNA partitioning , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Karl Münger,et al.  Biological activities and molecular targets of the human papillomavirus E7 oncoprotein , 2001, Oncogene.

[23]  L. Banks,et al.  The Human Papillomavirus E6 protein and its contribution to malignant progression , 2001, Oncogene.

[24]  P. Stern,et al.  The Human Papillomavirus (HPV) 16 E2 Protein Induces Apoptosis in the Absence of Other HPV Proteins and via a p53-dependent Pathway* , 2000, The Journal of Biological Chemistry.

[25]  E. Androphy,et al.  Transactivation-Competent Bovine Papillomavirus E2 Protein Is Specifically Required for Efficient Repression of Human Papillomavirus Oncogene Expression and for Acute Growth Inhibition of Cervical Carcinoma Cell Lines , 1998, Journal of Virology.

[26]  M. Yaniv,et al.  Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis , 1997, The EMBO journal.

[27]  P. Howley,et al.  Suppression of cellular proliferation by the papillomavirus E2 protein , 1995, Journal of virology.

[28]  P. Lambert,et al.  Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells , 1995, Journal of virology.

[29]  J. Settleman,et al.  Inhibition of cervical carcinoma cell line proliferation by the introduction of a bovine papillomavirus regulatory gene , 1993, Journal of virology.

[30]  P. Howley,et al.  Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[31]  M. Wagatsuma,et al.  Analysis of integrated human papillomavirus type 16 DNA in cervical cancers: amplification of viral sequences together with cellular flanking sequences , 1990, Journal of virology.

[32]  M. Yaniv,et al.  The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes , 1989, Journal of virology.

[33]  L. Gissmann,et al.  The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. , 1985, The Journal of general virology.

[34]  Wolfgang Mayer,et al.  Structure and transcription of human papillomavirus sequences in cervical carcinoma cells , 1985, Nature.